Research Brief
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon P. Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima and David A. Barbie
Shunsuke Kitajima
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Elena Ivanova
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Sujuan Guo
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Ryohei Yoshida
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Marco Campisi
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.
Shriram K. Sundararaman
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.University of Virginia School of Medicine, University of Virginia, Charlottesville, Virginia.
Shoichiro Tange
Department of Human Genetics, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan.
Yoichiro Mitsuishi
Department of Respiratory Medicine, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Tran C. Thai
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Sayuri Masuda
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Brandon P. Piel
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Lynette M. Sholl
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Paul T. Kirschmeier
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cloud P. Paweletz
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
Hideo Watanabe
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Mamiko Yajima
MCB Department, Brown University, Providence, Rhode Island.
David A. Barbie
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
DOI: 10.1158/2159-8290.CD-18-0689 Published January 2019

Log in using your username and password
Purchase Short Term Access
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
January 2019
Volume 9, Issue 1
Volume 9, Issue 1
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon P. Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima and David A. Barbie
Cancer Discov January 1 2019 (9) (1) 34-45; DOI: 10.1158/2159-8290.CD-18-0689
Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer
Shunsuke Kitajima, Elena Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon P. Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima and David A. Barbie
Cancer Discov January 1 2019 (9) (1) 34-45; DOI: 10.1158/2159-8290.CD-18-0689
Jump to section
Advertisement